These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 6431597
21. [Oral contraception and its beneficial gynecological effects]. Belaisch J, Hommais-loufrani B. Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188 [Abstract] [Full Text] [Related]
22. Oral contraceptives and breast cancer. Johnson KH, Millard PS. J Fam Pract; 1996 Oct; 43(4):340-1. PubMed ID: 8874363 [Abstract] [Full Text] [Related]
23. Review: oral contraceptives and menopausal estrogens in relation to breast neoplasia. Brzezinski A, Schenker JG. Isr J Med Sci; 1982 Apr; 18(4):433-8. PubMed ID: 7045033 [Abstract] [Full Text] [Related]
25. Update on cancer risk and oral contraceptives. Engel NS. MCN Am J Matern Child Nurs; 1990 Apr; 15(1):37. PubMed ID: 2105427 [Abstract] [Full Text] [Related]
26. The pill and the breast. Drife JO. IPPF Med Bull; 1984 Dec; 18(6):1-2. PubMed ID: 12313402 [Abstract] [Full Text] [Related]
27. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women. Gammon MD, Hibshoosh H, Terry MB, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD. Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436 [Abstract] [Full Text] [Related]
28. [New discoveries on oral contraceptives and risk of breast cancer. International data show a moderate increase in risk]. Persson I. Lakartidningen; 1996 Dec 11; 93(50):4613-6. PubMed ID: 8999253 [Abstract] [Full Text] [Related]
29. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments]. Le Coutour X. NPN Med; 1985 Apr 02; 5(88):471-6. PubMed ID: 12315304 [Abstract] [Full Text] [Related]
30. Oral contraceptive use and the risk of breast cancer in young women. Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep; 1984 Jun 29; 33(25):353-4. PubMed ID: 6427584 [Abstract] [Full Text] [Related]
32. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer. Kaunitz AM. J Reprod Med; 1996 May 29; 41(5 Suppl):419-27. PubMed ID: 8725705 [Abstract] [Full Text] [Related]
33. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity. Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM. Thromb Haemost; 1995 Sep 29; 74(3):928-32. PubMed ID: 8571323 [Abstract] [Full Text] [Related]
34. [The pill and cancer of the breast and cervix uteri]. Pedersen A. Ugeskr Laeger; 1984 Apr 02; 146(14):1063-6. PubMed ID: 6730039 [Abstract] [Full Text] [Related]
35. [The present state of research on the relationship of oral contraceptives to breast cancer]. Pike MC. Contracept Fertil Sex (Paris); 1985 Jan 02; 13(1 Suppl):329-38. PubMed ID: 12280203 [Abstract] [Full Text] [Related]
37. Oral contraceptive risks: a realistic appraisal. Bressler R, Durand JL. Drug Ther (NY); 1979 Oct 02; 9(10):81-95. PubMed ID: 12279276 [Abstract] [Full Text] [Related]
38. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study. Lidegaard O. Acta Obstet Gynecol Scand; 1997 Mar 02; 76(3):252-60. PubMed ID: 9093141 [Abstract] [Full Text] [Related]
39. Statement on steroidal oral contraceptives. International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP. IPPF Med Bull; 1981 Dec 02; 15(6):3-5. PubMed ID: 12263973 [Abstract] [Full Text] [Related]
40. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel. Jick SS, Kaye JA, Russmann S, Jick H. Contraception; 2006 Jun 02; 73(6):566-70. PubMed ID: 16730485 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]